INGN News and Press, Inogen Inc From 03/06/23

2023-03-06 13:46:43 ET Summary Supply chain issues caused major problems for Inogen in FY22, and continued headwinds are expected in FY23. Management expects operational performance to improve in late FY23 but indicates that returning to profitability is a medium-to-long-term ende...

Inogen Inc. (INGN) Q4 2022 Results Conference Call February 23, 2023 05:00 PM ET Company Participants Agnes Lee - SVP of IR and Strategic Planning Nabil Shabshab - President and CEO Kristin Caltrider - CFO Conference Call Participants Matthew Blackman - Sti...

Inogen press release ( NASDAQ: INGN ): Q4 Non-GAAP EPS of -$0.57 beats by $0.08 . Revenue of $88.09M (+15.3% Y/Y) misses by $1.61M . For further details see: Inogen Non-GAAP EPS of -$0.57 beats by $0.08, revenue of $88.09M misses by $1.61M

Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will host a conference call on Monday, February 27, 2023, at 10:00 a.m. Eastern Time. At the event, Nabil Shabshab, President and Chie...

Fourth Quarter Year-over-Year Revenue Growth of 15.3% Full Year 2022 Year-over-Year Revenue Growth of 5.4% Inogen, Inc . (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial resu...

The shares of Inogen Inc. ( NASDAQ: INGN ) fell in the morning hours Tuesday after William Blair downgraded the MedTech company to Market Perform from Outperform, citing the impact of macro headwinds on medical equipment. “….we believe that there could be more headwinds ...

Inogen ( NASDAQ: INGN ) estimates Q4 total revenue to be in the range of $87.5M to $88.5M, representing Y/Y growth of 14.5% to 15.8%, vs consensus of $89.48M . FY22 total revenue is expected to be in the range of $376.7M to $377.7M, representing Y/Y growth of 5.2% to...

Inogen Announces Receipt of EU Quality Management Certification under the Medical Device Regulation for Portable Oxygen Concentrators Inogen Announces U.S. Food and Drug Administration 510(k) clearance for its Latest Portable Oxygen Concentrator Inogen to Launch New Rove Series Po...

Inogen to Present at J.P. Morgan Healthcare Conference This Week Inogen to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023 Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the...

Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will present at the following investor conferences: Stifel 2022 Healthcare Conference on Tuesday, November 1...